|
|
|
|
| LEADER |
00000nam a2200000 4500 |
| 001 |
2701459 |
| 005 |
20030524072300.0 |
| 008 |
720419s1972 dcu b 000 0 eng |
| 003 |
ICU |
| 010 |
|
|
|a 71184410
|
| 035 |
|
|
|a (OCoLC)303606
|
| 040 |
|
|
|a DLC
|c DLC
|d CGU
|d OCoLC
|
| 049 |
|
|
|a CGUA
|
| 050 |
0 |
|
|a RM300
|b .A26
|
| 082 |
0 |
|
|a 615/.7
|
| 110 |
2 |
|
|a Academy of Pharmaceutical Sciences.
|0 http://id.loc.gov/authorities/names/n80084471
|1 http://viaf.org/viaf/156913406/
|1 http://viaf.org/viaf/130752301
|
| 245 |
1 |
0 |
|a Guidelines for biopharmaceutical studies in man.
|
| 260 |
|
|
|a Washington,
|c 1972.
|
| 300 |
|
|
|a 33 p.
|c 23 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 500 |
|
|
|a Prepared by its Committee on Biologic Performance of Drug Products.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 650 |
|
0 |
|a Drugs
|x Physiological effect.
|0 http://id.loc.gov/authorities/subjects/sh85039742
|
| 650 |
|
0 |
|a Drugs
|x Dosage.
|0 http://id.loc.gov/authorities/subjects/sh85039725
|
| 650 |
|
7 |
|a Drugs
|x Dosage
|2 fast
|0 http://id.worldcat.org/fast/fst01432036
|
| 650 |
|
7 |
|a Drugs
|x Physiological effect
|2 fast
|0 http://id.worldcat.org/fast/fst00898862
|
| 758 |
|
|
|1 http://worldcat.org/entity/work/id/1350428
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 6ba66f01-a390-5cee-b42f-4edefe801c73
|s 5f85009d-738e-5f4c-a4b8-f8960202c1a4
|
| 928 |
|
|
|t Dewey Decimal classification
|a 615.7 Y202
|l JCL
|c JCL-SciDDC
|i 3037580
|
| 927 |
|
|
|t Dewey Decimal classification
|a 615.7 Y202
|l JCL
|c JCL-SciDDC
|e CRERAR
|b 086967604
|i 4925494
|
